SEC Tracker
Get the app

Kyntra Bio KYNB

Andrew E. Singer reports stock option grant

Andrew E. Singer, insider filing for FGEN

Form
4
Filed
Importance
Routine
  1. Andrew E. Singer granted 14,000 stock options
  2. Exercise price $6.50
  3. Vesting over 12 quarterly installments
  4. Expiration Sep 30, 2036

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Kyntra Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Armata Pharmaceuticals ARMP public float $21M, Jun 30, 2025
  2. Imunon IMNN public float $21M, Jun 30, 2025
  3. Lunai Bioworks LNAI public float $21M, Dec 31, 2025
  4. Dare Bioscience DARE public float $21M, Jun 30, 2025
  5. Aptose Biosciences APTOF public float $22M, Jun 28, 2025

Data on this page was fetched . The filing on SEC.gov is the record.